Normalization of hemoglobin-based oxygen carrier-201 induced vasoconstriction: Targeting nitric oxide and endothelin
Hemoglobin-based oxygen carrier (HBOC)-201 is a cell-free modified hemoglobin solution potentially facilitating oxygen uptake and delivery in cardiovascular disorders and hemorrhagic shock. Clinical use has been hampered by vasoconstriction in the systemic and pulmonary beds. Therefore, we aimed to 1) determine the possibility of counteracting HBOC-201-induced pressor effects with either adenosine (ADO) or nitroglycerin (NTG); 2) assess the potential roles of nitric oxide (NO) scavenging, reactive oxygen species (ROS), and endothelin (ET) in mediating the observed vasoconstriction; and 3) compare these effects in resting and exercising swine. Chronically instrumented swine were studied at rest and during exercise after administration of HBOC-201 alone or in combination with ADO. The role of NO was assessed by supplementation with NTG or administration of the eNOS inhibitor Nω-nitro-L-arginine. Alternative vasoactive pathways were investigated via intravenous administration of the ETA/ETB receptor blocker tezosentan or a mixture of ROS scavengers. The systemic and to a lesser extent the pulmonary pressor effects of HBOC-201 could be counteracted by ADO; however, dosage titration was very important to avoid systemic hypotension. Similarly, supplementation of NO with NTG negated the pressor effects but also required titration of the dose. The pressor response to HBOC-201 was reduced after eNOS inhibition and abolished by simultaneous ETA/ETB receptor blockade, while ROS scavenging had no effect. In conclusion, the pressor response to HBOC-201 is mediated by vasoconstriction due to NO scavenging and production of ET. Further research should explore the effect of longer-acting ET receptor blockers to counteract the side effect of hemoglobin-based oxygen carriers.
|Keywords||Animal study, Critical care medicine, Endothelin, Hemoglobin-based oxygen carrier, Hypertension, Nitric oxide, Reactive oxygen species, Vasoconstriction|
|Persistent URL||dx.doi.org/10.1152/japplphysiol.00677.2016, hdl.handle.net/1765/103317|
|Journal||Journal of Applied Physiology|
Taverne, Y.J.H.J, de Wijs-Meijler, D, te Lintel Hekkert, M, Moon-Massat, P.F. (Paula F.), Dubé, G.P. (Gregory P.), Duncker, D.J.G.M, & Merkus, D. (2017). Normalization of hemoglobin-based oxygen carrier-201 induced vasoconstriction: Targeting nitric oxide and endothelin. Journal of Applied Physiology, 122(5), 1227–1237. doi:10.1152/japplphysiol.00677.2016